| |
| |
|
| Insider
Information: |
Cole G Bradley |
| Relationship: |
|
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
65,221 |
|
|
Indirect Shares
|
12,334 |
|
|
| Direct
Value |
$3,567,717 |
|
|
|
Indirect Value
|
$725,856 |
|
|
| Total
Shares |
77,555 |
|
|
| Total
Value |
$4,293,572 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genomic Health Inc |
GHDX |
CFO |
2018-10-10 |
45,372 |
2019-11-08 |
0 |
Premium* |
|
|
Exact Sciences Corp |
EXAS |
General Manager - Diag... |
2020-02-19 |
10,194 |
2020-01-16 |
12,334 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2023-06-02 |
4,655 |
2022-06-10 |
0 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2023-06-29 |
5,000 |
2023-06-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KNSA |
Kiniksa Pharmaceuticals, ... |
|
– • – |
2023-06-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-06-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,825 |
4,655 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
830 |
830 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
General Manager - Diagnostics |
• – – |
2020-02-19 |
4 |
AS |
$100.00 |
$2,735,600 |
D/D |
(27,356) |
10,194 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
General Manager - Diagnostics |
• – – |
2020-02-19 |
4 |
OE |
$35.28 |
$620,776 |
D/D |
17,356 |
37,550 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
General Manager - Diagnostics |
• – – |
2020-01-16 |
4 |
AS |
$90.30 |
$903,000 |
D/D |
(10,000) |
8,653 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
General Manager - Diagnostics |
• – – |
2019-12-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,334 |
18,653 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
General Manager - Diagnostics |
• – – |
2019-11-21 |
4 |
AS |
$80.38 |
$2,251,926 |
D/D |
(28,016) |
30,987 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-11-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(39,179) |
0 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-10-07 |
4 |
AS |
$69.01 |
$1,556,886 |
I/I |
(22,560) |
38,970 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-10-07 |
4 |
OE |
$30.84 |
$695,750 |
I/I |
22,560 |
61,530 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-09-10 |
4 |
AS |
$71.60 |
$1,300,277 |
I/I |
(18,112) |
38,970 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-09-10 |
4 |
OE |
$28.05 |
$508,042 |
I/I |
18,112 |
57,082 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-09-09 |
4 |
OE |
$28.05 |
$701,250 |
I/I |
25,000 |
63,970 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-09-09 |
4 |
AS |
$72.10 |
$1,813,071 |
I/I |
(25,000) |
38,970 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-08-12 |
4 |
AS |
$73.30 |
$4,398,588 |
I/I |
(60,000) |
38,970 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-08-12 |
4 |
OE |
$29.34 |
$1,760,400 |
I/I |
60,000 |
98,970 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-08-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,000 |
38,970 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-07-09 |
4 |
OE |
$17.18 |
$111,172 |
I/I |
6,471 |
50,441 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-07-09 |
4 |
AS |
$56.23 |
$369,386 |
I/I |
(6,471) |
43,970 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-06-11 |
4 |
AS |
$51.30 |
$257,281 |
I/I |
(5,000) |
43,722 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-06-11 |
4 |
OE |
$17.18 |
$85,900 |
I/I |
5,000 |
48,722 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-04-09 |
4 |
AS |
$67.59 |
$1,014,120 |
I/I |
(15,000) |
43,722 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-04-09 |
4 |
OE |
$17.18 |
$315,700 |
I/I |
15,000 |
58,722 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-03-12 |
4 |
OE |
$17.18 |
$315,700 |
I/I |
15,000 |
58,722 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
